Navigation Links
TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials

e viral load (less than 50 copies/mL), compared with those in the placebo arm (39 percent; n=119) [p=0.005]. Similarly, in DUET-2, significantly more patients (62 percent; n=183) in the TMC125 arm achieved a confirmed undetectable viral load compared with those in the placebo arm (44 percent; n=129) [p=0.0003].

"The NNRTI class has been one of the cornerstones of antiretroviral therapy for more than a decade. However, NNRTI resistance limits the use of this class in treatment-experienced patients," said Tony Mills, MD, HIV specialist in private practice, Los Angeles, and assistant professor of clinical medicine, UCLA. "The results that we saw in DUET-1 and -2 in patients with documented NNRTI resistance are very exciting and suggest that in the future, we may have the ability to sequence NNRTIs in HIV treatment."

24-Week Safety Findings

In DUET-1, the most commonly reported adverse events (>=10%), regardless of causality, among patients in the TMC125 arm vs. placebo arm were rash (20 percent vs. 10 percent), nausea (14 percent vs. 12 percent), diarrhea (12 percent vs. 20 percent), headache (10 percent vs. 13 percent), nervous system disorders including headache, somnolence, dizziness, and memory impairment (15 percent vs. 20 percent), and psychiatric disorders including insomnia, anxiety, depression and nightmare (10 percent vs. 14 percent). In the TMC125 arm, 42 patients discontinued treatment for any reason vs. 56 patients in the placebo arm.

In DUET-2, the most commonly reported adverse events (>=10%), regardless of causality, among patients receiving TMC125 vs. placebo were rash (14 percent vs. 9 percent), diarrhea (18 percent vs. 20 percent), nausea (14 percent vs. 10 percent), injection site reaction (13 percent vs. 15 percent), headache (9 percent vs. 11 percent), fatigue (9 percent vs. 10 percent), nervous system disorders (15 percent vs. 17 percent) and psychiatric disorders (16 percent vs. 17 percent). In the TMC125 arm, 51 pati
'"/>




Page: 1 2 3 4

Related medicine technology :

1. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
2. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
5. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
6. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
7. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
8. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
9. Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
10. OSI Pharmaceuticals Announces Pivotal Phase III Tarceva Study Published in the Journal of Clinical Oncology Showed Survival Improvement in Patients with Pancreatic Cancer
11. Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
Post Your Comments:
(Date:5/22/2013)... Advanced Prenatal Therapeutics (APT), a privately held ... alleviate the high blood pressure and other symptoms associated ... be the first medical device specifically designed to treat ... Every year, preeclampsia affects approximately 300,000 pregnant ... It is characterized by high blood pressure and proteinuria ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... is investigating potential claims on behalf of purchasers ... or the "Company") (NasdaqGS: AMAG -News).  The investigation ... violated federal securities laws. On May ... 10.73% during intraday trading after the company announced ...
(Date:5/22/2013)... 2013  The Leukemia & Lymphoma Society (LLS) is ... LLC, a joint venture between ImmunGene and Caliber, to ... Phase I clinical trial for a novel fusion protein ... patients with indolent lymphomas who do not respond to ... IGN002, is a new class of biotherapeutics produced by ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
... 2012  Niagara Thermal Products LLC is pleased to announce ... acquisition brings together two highly regarded names in the ... in the aerospace, defense and electronics markets. ... addition of Kittredge,s industry recognized dip brazing, welding, machining ...
... N.C., Jan. 23, 2012  As the influence of Managed ... that biopharma companies carry out as part of interacting ... device leaders have placed an increased importance on these ... closely intertwined with marketplace success. On average, ...
Cached Medicine Technology:Niagara Thermal Products LLC Announces the Acquisition of J. Kittredge & Sons, Inc. 2Niagara Thermal Products LLC Announces the Acquisition of J. Kittredge & Sons, Inc. 3Pharmaceutical Industry Places Newfound Emphasis on Managed Care Organizations 2Pharmaceutical Industry Places Newfound Emphasis on Managed Care Organizations 3
(Date:5/22/2013)... OH (PRWEB) May 22, 2013 The ... among consumers, however cutting through marketing claims to compare ... The Sleepy Shopper, a bed blog , offers ... of leading types in their latest article. , Titled ... Benefits ”, this article guides readers through the basics ...
(Date:5/22/2013)... The Yoga of Lady Niguma was created by a female ... This is the oldest yoga found in written form (in a ... partner of renowned Indian master and yogi Naropa, and the yoga ... female yoga master. , Lady Niguma taught the practice to ... a long lineage to the second Dalai Lama, Gendun Gyatso. While ...
(Date:5/22/2013)... Jury deliberations are now underway in Washington ... da Vinci lawsuit, Bernstein Liebhard LLP reports. According ... who allegedly died of da Vinci surgery complications following prostate ... from Intuitive Surgical, Inc. Among other things, they allege ... da Vinci Surgical System in its efforts to drive sales ...
(Date:5/22/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- Anyone who ... something about feet that fungi seem to like. But ... fungal groups that live on your skin -- and, ... It,s no secret that the human body is awash ... both outside and inside. And it,s mainly a friendly ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 DePuy ... the DePuy Pinnacle Hip Replacement System continue to move ... Court, Bernstein Liebhard LLP reports. According to an ... Orthopaedics to produce monitoring reports associated with a 2007 ... medical device marketing practices. Plaintiffs maintained in their ...
Breaking Medicine News(10 mins):Health News:Mattress Comparison Overview Released by The Sleepy Shopper; Compares Top Types and Brands 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Scientists Map the Fungi on Your Feet 2Health News:Scientists Map the Fungi on Your Feet 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3
... March 12 Professional Healthcare Resources, Inc., a ... Virginia, Washington DC, and Maryland, is pleased to ... by CHAP (the Community Health Accreditation Program), the ... accreditation process involved an in depth review of ...
... attacks than their predecessors, researchers say , , THURSDAY, March 12 ... even when compared with their counterparts 10 or 20 years ... aging boomers are being hospitalized for heart attacks now than ... in cases could place a big burden on cardiac care ...
... Community Suggests Adult Stem Cell Advances Could Be ... Calif., March 12 Adult Stem Cell scientists ... order repealing restrictions on Embryonic Stem Cell research ... and resources away from the promising Adult Stem ...
... diverse individuals with diabetes has found that home telemonitoring of ... similar group that was not monitored. Diabetes is the ... , The study of 387 diabetics and 387 individuals without ... Journal of Telemedicine and Telecare . , The researchers, led ...
... - CRH Medical Corporation (CRM:TSX-V) announced today that its ... on the nationally syndicated television program The Doctors. The ... local listings may be found at www.thedoctorstv.com . ... the # 1 new syndicated series, will receive the ...
... NEW BRUNSWICK, N.J., March 12 ... a pre-recorded webcast for financial analysts on Sunday, March 15 ... Institute of Pain 5th World Congress (WIP) in New York ... release (ER), a novel centrally acting oral analgesic, will be ...
Cached Medicine News:Health News:Professional Healthcare's Hospice Program Receives CHAP Accreditation 2Health News:Aging Baby Boomers May Swamp Cardiac Care 2Health News:Aging Baby Boomers May Swamp Cardiac Care 3Health News:Will Obama's Stem Cell Announcement Doom Promising Adult Stem Cell Research? 2Health News:Telehealth for diabetes promotes aging at home, not in the hospital 2Health News:CRH O'Regan Hemorrhoid Banding system featured on a nationally syndicated television program 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: